Jacobio Pharmaceuticals Group Co Ltd Sustainability Reports
Jacobio Pharmaceuticals Group Co., Ltd. is a clinical-stage biopharmaceutical company focused on the in-house discovery and development of innovative oncology therapies. The company specializes in targeting undruggable protein pathways, such as SHP2 and KRAS, to address unmet medical needs globally.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
LEI: 836800ZEHY59DQTEOW40
FIGI: BBG00YGD10T6
6 reports from 2020 to 2025
